Rx for Indian pharma

The decision of the USFDA to put Ranbaxy's bulk drug unit in Toansa under import alert is a big blow to it. A lot has to be done if India is to be called the global pharmacy of the world, now and in future. Daiichi-Sankyo, the Japanese innovator company, is in control of Ranbaxy for almost five years but regulatory problems continue to plague the company. The USFDA is looking at Ranbaxy with a magnifying lens.

Read Full Story>>